【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05.Product Profiles
05.1.1 Nexavar
05.1.2 Avastin
05.1.3 Votrient
05.1.4 Afinitor/Votubia
05.1.5 Proleukin
05.1.6 Inlyta
05.1.7 Sutent
05.1.8 Torisel
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.1.1 Types of Kidney Cancer
07.1.2 Benign Kidney Tumors
07.2 Risk Factors
07.2.1 Lifestyle and Job-related Risk Factors
07.2.2 Genetic and Hereditary Risk Factors
07.2.3 Other Risk Factors
07.3 Etiology and Pathogenesis
07.3.1 Inherited Gene Mutations
07.3.2 Acquired Gene Mutations
07.4 Signs and Symptoms
07.5 Diagnosis
07.5.1 Medical History and Physical Exam
07.5.2 Lab Tests
07.5.3 Imaging Tests
07.5.4 Biopsy
07.6 Staging
07.6.1 TNM Staging System
07.7 Management
07.7.1 Surgery
07.7.2 Ablation and Other Local Therapies
07.7.3 Radiation Therapy
07.7.4 Targeted Therapy
07.7.5 Biologic Therapy (Immunotherapy)
07.7.6 Chemotherapy
07.8 Epidemiology
07.9 Economic Burden
08.Pipeline Analysis
08.1 Key Information on Pipeline Candidates
08.1.1 AGS-003
08.1.2 Rencarex
08.1.3 Cometriq
08.1.4 IMA901
08.1.5 AV-951
08.1.6 TroVax
08.1.7 MPDL3280A
08.1.8 Opdivo
08.1.9 Naptumomab Estafenatox
08.1.10 Carfilzomib
09.Market Landscape
09.1 Market Overview
09.2 Market Size and Forecast
09.3 Five Forces Analysis
10.Market Segmentation by Molecule Type
10.1 Small Molecules
10.2 Biologics
11.Geographical Segmentation
12.Buying Criteria
13.Market Growth Drivers
14.Drivers and Their Impact
15.Market Challenges
16.Impact of Drivers and Challenges
17.Market Trends
18.Trends and Their Impact
19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Bayer
19.2.2 F. Hoffmann-La Roche
19.2.3 GlaxoSmithKline
19.2.4 Novartis
19.2.5 Pfizer
19.3 Other and Future Prominent Vendors
20.Global Kidney Cancer Drugs Market: Key Takeaways
21.Key Vendor Analysis
21.1 Bayer
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2014
21.1.4 Business Segmentation by Revenue 2013 and 2014
21.1.5 Geographical Segmentation by Revenue 2014
21.1.6 Business Strategy
21.1.7 Recent Developments
21.1.8 SWOT Analysis
21.2 F. Hoffmann-La Roche
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Sales by Geography
21.2.6 Business Strategy
21.2.7 Key Information
21.2.8 SWOT Analysis
21.3 GlaxoSmithKline
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2014
21.3.4 Business Segmentation by Revenue 2013 and 2014
21.3.5 Geographical Segmentation by Revenue 2014
21.3.6 Business Strategy
21.3.7 Recent Developments
21.3.8 SWOT Analysis
21.4 Novartis
21.4.1 Key Facts
21.4.2 Business Description
21.4.3 Business Segmentation
21.4.4 Revenue by Business Segmentation
21.4.5 Revenue Comparison 2012 and 2013
21.4.6 Sales by Geography
21.4.7 Business Strategy
21.4.8 Key Developments
21.4.9 SWOT Analysis
21.5 Pfizer
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2014
21.5.4 Business Segmentation by Revenue 2013 and 2014
21.5.5 Geographical Segmentation by Revenue 2014
21.5.6 Business Strategy
21.5.7 Key Developments
21.5.8 SWOT Analysis
22.Other Reports in This Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Types of Kidney Cancer
Exhibit 3: Types of Benign Kidney Tumor
Exhibit 4: Prevalence of Kidney Cancer by Gender
Exhibit 5: Global Kidney Cancer Drugs Market: Pipeline Portfolio
Exhibit 6: Global Kidney Cancer Drugs Market 2014-2019 ($ billions)
Exhibit 7: Segmentation of Global Kidney Cancer Drugs Market by Molecule Type
Exhibit 8: Segmentation of Global Kidney Cancer Drugs Market by Geography 2014
Exhibit 9: Major Drivers in Global Kidney Cancer Drugs Market
Exhibit 10: Major Challenges in Global Kidney Cancer Drugs Market
Exhibit 11: Major Trends of Global Kidney Cancer Drugs Market
Exhibit 12: Bayer: YoY Growth and Revenue of Nexavar 2010-2014 ($ millions)
Exhibit 13: F. Hoffmann-La Roche: YoY Growth and Revenue of Avastin 2010-2014 ($ millions)
Exhibit 14: GlaxoSmithKline: YoY Growth and Revenue of Votrient 2010-2014 ($ millions)
Exhibit 15: GlaxoSmithKline: Revenue of Votrient by Region 2010-2014 ($ millions)
Exhibit 16: Novartis: YoY Growth and Revenue of Afinitor 2010-2014 ($ millions)
Exhibit 17: Novartis: Revenue of Afinitor by Region 2012-2013 ($ millions)
Exhibit 18: Novartis: YoY Growth and Revenue of Proleukin 2012-2014 ($ millions)
Exhibit 19: Pfizer: YoY Growth and Revenue of Inlyta 2012-2014 ($ millions)
Exhibit 20: Pfizer: YoY Growth and Revenue of Sutent 2010-2014 ($ millions)
Exhibit 21: Global Kidney Cancer Drugs Market: Key Takeaways
Exhibit 22: Bayer: Business Segmentation by Revenue 2014
Exhibit 23: Bayer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 24: Bayer: Geographical Segmentation by Revenue 2014
Exhibit 25: Business Segmentation of F. Hoffmann-La Roche 2013
Exhibit 26: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 27: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 28: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
Exhibit 29: GlaxoSmithKline: Business Segmentation by Revenue 2014
Exhibit 30: GlaxoSmithKline: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 31: GlaxoSmithKline: Geographical Segmentation by Revenue 2014
Exhibit 32: Novartis: Business Segmentation
Exhibit 33: Novartis: Revenue by Business Segmentation 2013
Exhibit 34: Novartis: Revenue by Business Segmentation 2012 and 2013 ($ millions)
Exhibit 35: Novartis: Revenue by Geographical Segmentation 2013
Exhibit 36: Pfizer: Business Segmentation by Revenue 2014
Exhibit 37: Pfizer: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 38: Pfizer: Geographical Segmentation by Revenue 2014
【レポート販売概要】
■ タイトル：腎臓がん治療薬の世界市場2015-2019■ 英文：Global Kidney Cancer Drugs Market 2015-2019
■ 発行日：2015年7月1日
■ 調査会社：Technavio
■ 商品コード：IRTNTR6298
■ 調査対象地域：グローバル
- 電気自動車用リチウムイオンバッテリーの世界市場About Li-ion Battery for AEVs Li-ion batteries are extensively used as a power source in AEVs. They are used as an alternative source of power in HEVs, and as a primary source of power in BEVs and PHEVs. BEVs and PHEVs use electric motors, powered by Li-ion batteries, for propulsion. The application base of Li-ion batteries is higher in BEVs and PHEVs because of their high energy density and long …
- コハク酸の世界市場：石油系コハク酸、バイオ系コハク酸The market size of succinic acid is projected to reach USD 701.0 Million by 2021, at a CAGR of 28.0%. It is projected to reach 251.3 kilotons by 2021, at a CAGR of 27.2% between 2016 and 2021. The growing manufacturing industries, increasing demand for bio-based succinic acid in Western Europe, increasing demand for polyurethane in North America, and continuous agreement/collaboration, joint ventu …
- 小売における人工知能（AI）の世界市場2019-2023Global Artificial Intelligence (AI) Market: About this market Artificial Intelligence (Al) solutions are a convergence of hardware, software, and services to perform computing-based reasoning and understanding to emulate the human brain. Technavio’s artificial intelligence (AI) in retail sector market analysis considers sales from sales and marketing, in-store, planning, procurement and production …
- 世界の4WD（四輪駆動）及びADW（全輪駆動）小型車市場動向と予測（～2029）This latest just-auto report edition offers a global review of the OE 4WD and AWD sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE 4WD and AWD market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospec …
- アジアの空港/海港および産業用タイヤ市場2016-2020About Port and Industrial Tire Market in Asia Pacific Port and industrial tires are designed for use in port handling equipment and airport ground handling equipment. These tires fall under the tire market segment called off-the-road (OTR) tires. The OTR tires can be segmented based on end-users, or the industries that use them, which include mining, construction, seaports, and airports among othe …
- 世界の栄養補助成分市場動向（2014-2018）About Nutraceutical Ingredients Nutraceuticals are products that provide pharmacological, or health and medicinal benefits in addition to nutrition. Nutraceutical ingredients are key functional ingredients or components of nutraceuticals. These ingredients may be natural, bioactive substances or chemical compounds designed to help prevent diseases and promote health. TechNavio's analysts forecast …
- 世界のがん治療用樹状細胞ワクチン市場Dendritic cells are branched cells found in lymphoid organs and they are responsible for antigen display and T-cell activation. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. In 1868, Paul Langerhans discovered dendritic cells and thought that they are part of nervous system because of their branched structure. Until 1973 their …
- CLP Holdings Limited：発電所及びSWOT分析2013CLP Holdings Limited - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized an …
- 発泡剤の世界市場予測（～2026年）“Growing use of polymer foam in industries such as construction, automotive, and electronics, to drive the blowing agent market”The blowing agent market size is estimated to be USD 1.5 billion in 2019 and is projected to reach USD 2.2 billion by 2026, at a CAGR of 5.8%. The increasing polymeric foam application in industries such as packaging, automotive, building & construction, marine, transport …
- 世界のモバイル教育（m-Education）市場動向（2014-2018）About mobile Education m-Education is the ability to provide educational-related content on smartphones and tablets. Educational-related content refers to all the digital learning content provided on personal devices. m-Education service providers deliver learning solutions using the latest tools and technology, providing users with rich media and graphic-based learning. Since this form of learnin …
- マレーシアの健康サプリメント市場2015-2019Technavio’s research analyst predicts the health supplement market in Malaysia to grow at a CAGR of 7% during the forecast period. The rise in the aging population in Malaysia is the key driver for the market growth of this region. Products that prevent age-related disorders, such as those linked to the digestive system, and ones that help maintain blood sugar levels, are in high demand among this …
- 世界のポリオキシメチレン市場2015The Global Polyoxymethylene Industry Report 2015 is a professional and in-depth study on the current state of the Polyoxymethylene industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Polyoxymethylene market analysis is provided for the international markets including development trends, competitive lan …
- バイオ炭の世界市場分析：技術別（熱分解、ガス化、その他）、用途別（農業（畑作、畜産、その他）、その他）、地域別、セグメント予測、2012 – 2025The global biochar market is expected to reach USD 3.14 billion by 2025, according to a new report by Grand View Research, Inc. Globally increasing consumption of organic food has been a major factor driving market growth. In addition, growing awareness regarding the advantages of biochar as soil amendment is further supplementing demand for the global market.Biochar is an emerging industry and th …
- サプライチェーン分析の世界市場分析：ソリューション別（企画調達、製造、販売＆運営、物流分析、ビジュアライゼーション･レポート）、展開別、エンドユーザー別、地域別、セグメント予測、2014-2025The global supply chain analytics market is expected to reach USD 9.87 billion by 2025, according to a new study by Grand View Research, Inc. The growing need to manage a large amount of business data and use derived insights is optimizing the demand for supply chains. The increasing awareness among consumers regarding the benefits offered by supply chain analytics has encouraged organizations acr …
- Waldron Energy Corporation：石油・ガスバリューチェーン分析レポート2013Waldron Energy Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Waldron Energy Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Waldron Energy Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chai …
